FDA approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent, to determine the extent squamous cell carcinoma has spread in the body’s head and neck region.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
